Alkane oxidation by modified hydroxylases

Patent metadata

Field	Value
Publication number	US-11214817-B2
Application number	US-202016872275-A
Country	US
Kind code	B2
Filing date	May 11, 2020
Priority date	Mar 28, 2005
Publication date	Jan 4, 2022
Grant date	Jan 4, 2022

Abstract

This invention relates to modified hydroxylases. The invention further relates to cells expressing such modified hydroxylases and methods of producing hydroxylated alkanes by contacting a suitable substrate with such cells.

First claim

What is claimed is:

1. A polynucleotide that encodes a polypeptide that catalyzes the conversion of a (C 1 -C 12 )alkane to an alcohol,
wherein the polypeptide comprises SEQ ID NO: 1 and has one or more selective amino acid substitutions at residues 47, 74, 78, 94, 142, 175, 184, 188, 205, 226, 236, 252, 255, 290, 353, 366, 443, 464, and 710 in comparison to the amino acid sequence set forth in SEQ ID NO:1, and wherein the one or more selective amino acid substitutions are as follows:
(i) at positions selected from the group consisting of 47, 142, 205, 236, 252, 255, and 464 and any combination thereof, an amino acid residue selected from glycine (G), asparagine (N), glutamine (Q), serine (S), threonine (T), tyrosine (Y), and cysteine (C);
(ii) at positions selected from the group consisting of 94, 175, 184, 188, 290, 353, a and 366 or any combination thereof, an amino acid residue selected from alanine (A), valine (V), leucine (L), isoleucine (I), proline (P), and methionine (M);
(iii) at position 226, an amino acid selected from lysine (K) and arginine (R);
(iv) at positions 78 an amino acid selected from alanine (A), tyrosine (Y), phenylalanine (F), tryptophan (W) and histidine (H);
(v) at position 74, an amino acid selected from alanine (A), serine (S), and glutamic acid (E);
(vi) at position 443 an alanine (A) residue; and
(vii) at position 710 a threonine (T);
wherein the polypeptide comprises a glycine (G), asparagine (N), glutamine (Q), serine (S), threonine (T), tyrosine (Y), or cysteine (C) at position 82;
wherein the polypeptide comprises an isoleucine (I) at position 52; and
wherein the polypeptide comprises a tyrosine (Y), phenylalanine (F), tryptophan (W), or histidine (H) at position 328.

2. The polynucleotide of claim 1 , wherein the polypeptide encoded by the polynucleotide further comprises up to 50 conservative amino acid substitutions in comparison to the amino acid sequence set forth in SEQ ID NO:1.

3. The polynucleotide of claim 1 , wherein the polypeptide encoded by the polynucleotide further comprises up to 25 conservative amino acid substitutions in comparison to the amino acid sequence set forth in SEQ ID NO:1.

4. The polynucleotide of claim 1 , wherein the polypeptide encoded by the polynucleotide further comprises up to 10 conservative amino acid substitutions in comparison to the amino acid sequence set forth in SEQ ID NO:1.

5. The polynucleotide of claim 1 , wherein the polypeptide encoded by the polynucleotide further comprises up to 5 conservative amino acid substitutions in comparison to the amino acid sequence set forth in SEQ ID NO:1.

6. The polynucleotide of claim 1 , wherein the polypeptide encoded by the polynucleotide comprises at position 52 a leucine (L), at position 74 an alanine (A), at position 188 a leucine (L), and at position 366 an isoleucine (I).

7. The polynucleotide of claim 1 , wherein the polypeptide encoded by the polynucleotide comprises at position 47 a cysteine (C), at position 78 a phenylalanine (F), at position 82 a serine (S), at position 94 an isoleucine (I), at position 142 a serine (S), at position 175 an isoleucine (I), at position 184 a valine (V), at position 205 a cysteine (C), at position 226 an arginine (R), at position 236 a glutamine (Q), at position 252 a glycine (G), at position 255 a serine (S), at position 290 a valine (V), at position 328 a phenylalanine (F), and at position 353 a valine (V).

8. The polynucleotide of claim 6 , wherein the polypeptide encoded by the polynucleotide comprises at position 47 a cysteine (C), at position 78 a phenylalanine (F), at position 82 a serine (S), at position 94 an isoleucine (I), at position 142 a serine (S), at position 175 an isoleucine (I), at position 184 a valine (V), at position 205 a cysteine (C), at position 226 an arginine (R), at position 236 a glutamine (Q), at position 252 a glycine (G), at position 255 a serine (S), at position 290 a valine (V), at position 328 a phenylalanine (F), and at position 353 a valine (V).

9. The polynucleotide of claim 1 , wherein the polypeptide encoded by the polynucleotide comprises at position 464 a glycine (G), and at position 710 a threonine (T).

10. The polynucleotide of claim 7 , wherein the polypeptide encoded by the polynucleotide comprises at position 464 a glycine (G), and at position 710 a threonine (T).

11. The polynucleotide of claim 8 , wherein the polypeptide encoded by the polynucleotide comprises at position 464 a glycine (G), and at position 710 a threonine (T).

12. The polynucleotide of claim 1 , wherein the polynucleotide has at least 90% sequence identity to the sequence of SEQ ID NO:15 or SEQ ID NO:17.

13. The polynucleotide of claim 12 , wherein the polynucleotide has at least 95% sequence identity to the sequence of SEQ ID NO:15 or SEQ ID NO:17.

14. The polynucleotide of claim 1 , wherein the (C 1 -C 12 )alkane is selected from the group consisting of methane, propane, butane, pentane, hexane, heptane, octane, nonane, decane, undecane, and dodecane.

15. The polynucleotide of claim 1 , wherein the alcohol is selected from the group consisting of methanol, ethanol, propanol, butanol, pentanol, hexanol, heptanol, octanol, nonanol, decanol, undecanol, and dodecanol.

16. A vector comprising the polynucleotide of claim 1 .

17. The vector of claim 16 , wherein the vector is a plasmid, a cosmid, a phage, a virus, a bacterial artificial chromosome (BAC), or a yeast artificial chromosome (YAC).

18. A cell comprising the polynucleotide of claim 1 .

19. A cell comprising the vector of claim 16 .

20. The cell of claim 19 , wherein the cell is a prokaryote.

Assignees

• The California Institute Of Tech
• California Inst Of Techn

Inventors

• Arnold Frances
• Meinhold Peter
• Peters Matthew W
• Fasan Rudi
• Chen Mike M Y

Classifications

• C12P7/04 Primary

  acyclic · CPC title

• C12Y114/15

  with reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen (1.14.15) · CPC title

• C12N9/0071

  acting on paired donors with incorporation of molecular oxygen (1.14) · CPC title

• C12N9/0042

  NADPH-cytochrome P450 reductase (1.6.2.4) · CPC title

• C12N9/0077

  with a reduced iron-sulfur protein as one donor (1.14.15) · CPC title